You are here: Industry Insights > Remdesivir

News List

EMA recieves CMA application for remdesivir as a COVID-19 treatment europeanpharmaceuticalreview
June 10, 2020
The European Medicines Agency (EMA) said its assessment of the conditional marketing authorisation (CMA) application will be performed under a reduced timeframe, with a decision potentially delivered in weeks.
EMA to assess conditional authorisation of first COVID-19 treatment in European Union expresspharma
June 09, 2020
The assessment of the benefits and risks of remdesivir is being performed under a reduced timeline and an opinion could be issued within weeks, depending on the robustness of the data submitted.
Local API production in India for COVID-19 repurposed drugs may offer competitive advantage: GlobalData expresspharma
June 08, 2020
The advantages will be in terms of supply and price for the formulations manufactured in India, be it remdesivir, favipiravir or hydroxychloroquine (HCQ).
Maharashtra to procure 10,000 vials of remdesivir: Rajesh Tope expresspharma
June 08, 2020
Based on evidence from laboratory, animal and clinical studies, it has generated promising results in MERS-CoV and SARS which are also caused by corona virus, tweeted Tope.
Gilead’s remdesivir shows modest improvement in moderate COVID-19 patients expresspharma
June 03, 2020
Remdesivir, which is administered intravenously in hospital, is the first drug to show improvement in COVID-19 patients in formal clinical trials.
Gilead seeks marketing authorisation from CDSCO for remdesivir expresspharma
June 01, 2020
The medicine has been issued EUA by the US FDA to treat hospitalised coronavirus patients.
Roche Initiates Phase III Trial in COVID-19 Pneumonia contractpharma
May 29, 2020
To evaluate Actemra/RoActemra plus remdesivir in hospitalized patients with severe Pneumonia.
Peer-reviewed data shows remdesivir for COVID-19 improves time to recovery worldpharmanews
May 28, 2020
The investigational antiviral remdesivir is superior to the standard of care for the treatment of COVID-19, according to a report published today in The New England Journal of Medicine.
UK grants early access to Gilead’s remdesivir for Covid-19 pharmaceutical-technology
May 28, 2020
The UK Government has announced that some adults and adolescents hospitalised with Covid-19 on the National Health Service (NHS) will have access to Gilead Sciences’ remdesivir.
Montefiore, Einstein Test New Drug Combo to Conquer COVID-19 contractpharma
May 27, 2020
Researchers hope giving remdesivir along with a powerful anti-inflammatory could be the key to treating the most severe COVID-19 cases.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 14 15 Next page